Our Mission
At SmartHealth Inc., our mission is to advance and support complementary and alternative health research grounded in the sciences of bioenergetics and epigenetics, with the goal of expanding evidence-based approaches to human health and wellness, enabling practitioners and individuals to apply specific bio-energetic therapies for personalized, effective, and natural self-care.
Our Vision
Our vision is to make detailed and personalized epigenetic bioinformation available, on a standard computer or over the internet, to every individual, so they can take preemptive action in preventing accelerated aging and disease processes.
Our Research Interests
Through our comprehensive research, we explore how targeted energy medicines, modalities, and cutting-edge bioenergetic technologies may be used to support epigenetic function and help prevent the following conditions.
BREAST CANCER
One in eight women in the United States will be diagnosed with breast cancer in their lifetime. Breast cancer is a multifactorial disease influenced by genetic, hormonal, environmental, and biological factors. Chronic unresolved inflammation is widely recognized as a key biological mechanism that can contribute to disease initiation, progression, and outcomes, particularly when interacting with these risk factors.
Through our research, we explore preventive and risk-reduction approaches, with a focus on how bioenergetic and epigenetic mechanisms may influence inflammatory pathways, cellular regulation, and long-term health outcomes related to breast cancer.
ALZHEIMER'S DISEASE
Alzheimer’s disease is a neurodegenerative condition and the most common cause of dementia. It is characterized by the accumulation of amyloid-beta plaques and neurofibrillary tangles in the brain, which disrupt neuronal communication and contribute to progressive cognitive decline. Growing evidence suggests that metabolic dysfunction, chronic inflammation, and genetic susceptibility, including specific SNPs and mutations, play important roles in disease development and progression.
Through our research, we examine how epigenetic regulation and stress-responsive biological processes may influence neurological resilience and early disease risk. We are investigating whether bioenergetic interventions, including the SHOW Method, may support adaptive gene expression patterns and metabolic balance associated with cognitive health, particularly during early or preclinical stages.
PTSD & ANXIETY
Post-Traumatic Stress Disorder (PTSD) is a psychobiological condition that can develop following exposure to traumatic or life-threatening events such as combat, natural disasters, serious accidents, abuse, or significant emotional loss. PTSD is among the most prevalent diagnoses among U.S. military veterans, and suicide rates within this population remain a critical public-health concern. PTSD and anxiety disorders are also observed across the lifespan, including in children, adolescents, and young adults.
When PTSD and anxiety remain unrecognized or untreated, symptoms can intensify and contribute to secondary challenges, including substance use disorders. A significant proportion of affected individuals do not receive adequate care. In response to these challenges, Dr. Bernard Straile, DC, has developed a drug-free bioenergetic protocol designed to address stress-related physiological and genomic responses, including dysregulated stress signaling associated with SNPs and gene-environment interactions, using advanced biofeedback techniques.
AUTISM SPECTRUM DISORDER
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by differences in social communication, behavior, sensory processing, and cognitive functioning. Autism presents along a broad spectrum, with varying strengths, challenges, and support needs, and is understood to arise from complex interactions among genetic, neurological, and environmental factors.
Through our research, we explore how environmental stressors, immune responses, and epigenetic regulation may influence neurodevelopmental outcomes. We are investigating whether advanced stress-reduction and bioenergetic approaches, including the SHOW Method, may help modulate physiological responses to environmental and dietary sensitivities that are sometimes observed in individuals with ASD. This work focuses on supporting adaptive regulation and resilience rather than altering neurodiversity itself.
LACTOSE INTOLERANCE
Lactose intolerance is commonly associated with reduced activity of the lactase enzyme and is influenced by genetic variation, including specific single-nucleotide polymorphisms (SNPs). While genetic predisposition plays a role, emerging research suggests that gene expression, related to digestive enzymes, may also be influenced by epigenetic and metabolic factors.
Through our research, we are exploring whether bioenergetic biofeedback interventions may influence regulatory pathways involved in lactose metabolism. We hypothesize that bio-informational signaling may support adaptive expression of enzymes such as lactase and beta-galactosidase, potentially improving lactose tolerance. Although the precise mechanisms are not yet fully understood, this research aims to examine epigenetic modulation rather than permanent genetic alteration.
In our studies, lactose intolerance is assessed using standard allergy and symptom-based testing tools. Participants undergo a structured protocol of ASR biofeedback sessions, followed by repeat testing and symptom assessments three months after completion of the protocol to evaluate changes over time.